ProUroCare Medical Inc

Chart & Performance

D1W1MN

P/E

—

P/S

—

EPS

—

Div Yield, %

—

Shrs. gr., 5y

—

Rev. gr., 5y

Revenues

Net income

-3m

L+43.42%

CFO

-1m

L+33.79%

Notes

No notes on this company yet

Write a private note on this company, for your eyes only

Add note

Profile

ProUroCare Medical Inc. is dedicated to developing advanced products for the accurate identification and detailed assessment of male prostate diseases. The company's primary offering is the ProUroScan System, an innovative prostate imaging solution. This system empowers physicians to precisely document prostate irregularities that have been initially discovered through a digital rectal examination. ProUroCare has entered into strategic agreements with Artann Laboratories Inc., covering the licensing, ongoing development, and market commercialization of its ProUroScan System. The company was established in 1999 and is headquartered in Eden Prairie, Minnesota.

URL

http://www.prourocare.com/

IPO date

May 28, 2002

Employees

Domiciled in

Incorporated in

Valuation

No data to show